Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Silva Barbosa"'
Autor:
Grazielle Cerqueira de Carvalho, Catarina de Andrade Regis, Jamile Rosário Kalil, Liv Aparício Cerqueira, Daniel Silva Barbosa, Marina Pamponet Motta, Marília da Silva Nery, Maria Alice Pires Soares, Claudio Celestino Zollinger, Paulo Lisboa Bittencourt
Publikováno v:
Annals of Hepatology, Vol 11, Iss 1, Pp 90-95 (2012)
Background. Renal failure (RF) is reported to occur in 11-49% of the patients with decompensated end-stage liver disease (ESLD) and has been associated with increased mortality, particularly in the occurrence of hepatorenal syndrome (HRS) type 1. Aim
Externí odkaz:
https://doaj.org/article/5ce5fb9dd88e41489ff96a7c29dddf71
Autor:
Jamile Rosário Kalil, Liv Aparicio Cerqueira, Daniel Silva Barbosa, Marina Pamponet Motta, Marília da Silva Nery, Paulo Lisboa Bittencourt
Publikováno v:
Arquivos de Gastroenterologia, Vol 46, Iss 3, Pp 214-218 (2009)
CONTEXT: Treatment of hepatorenal syndrome type 1 (HRS-1) with splancnic vasoconstrictors and high-dose albumin has been associated with reversal of renal failure in approximately 60% to 80% of the cases in pilot or uncontrolled studies. OBJECTIVE: T
Externí odkaz:
https://doaj.org/article/1cd9e02b7c204a0a8fdca0e509512b49
Autor:
Jamile Rosário Kalil, Marina Pamponet Motta, Grazielle Cerqueira de Carvalho, Liv Aparicio Cerqueira, Catarina de Andrade Regis, Marília da Silva Nery, Paulo Lisboa Bittencourt, Daniel Silva Barbosa, Maria Alice Pires Soares, Cláudio Celestino Zollinger
Publikováno v:
Annals of Hepatology, Vol 11, Iss 1, Pp 90-95 (2012)
ResearcherID
ResearcherID
Background. Renal failure (RF) is reported to occur in 11-49% of the patients with decompensated end-stage liver disease (ESLD) and has been associated with increased mortality, particularly in the occurrence of hepatorenal syndrome (HRS) type 1. Aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4719052dede85a172ee8195997c8725e
http://www.sciencedirect.com/science/article/pii/S1665268119314917
http://www.sciencedirect.com/science/article/pii/S1665268119314917
Autor:
Liv Aparicio Cerqueira, Daniel Silva Barbosa, Marília da Silva Nery, Paulo Lisboa Bittencourt, Marina Pamponet Motta, Jamile Rosário Kalil
Publikováno v:
Arquivos de Gastroenterologia v.46 n.3 2009
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
CONTEXTO: O tratamento da sindrome hepatorrenal do tipo 1 (SHR-1) com vasoconstritores esplâncnicos e albumina intravenosa tem se associado, em relatos de caso e estudos piloto nao-controlados, a reversao da insuficiencia renal em 60%-80% dos pacien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef5ca717c5b8c1e7b179a1cec25a497
https://doi.org/10.1590/s0004-28032009000300014
https://doi.org/10.1590/s0004-28032009000300014